Dometuss-nr
Product Images NDC 53809-240

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dometuss-nr (NDC 53809-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Domel Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 Tablet Bottle Label)

Principal Display Panel (100 Tablet Bottle Label)
This product is a combination of a cough suppressant (Dextromethorphan HBr), an antihistamine (Chlorpheniramine Maleate), and a nasal decongestant (Phenylephrine HCI), which temporarily relieves symptoms of the common cold, such as runny nose, sneezing, and coughing. The user must be cautious not to exceed the recommended dosage and to ask a doctor before use in case of potential heart disease, thyroid disease, or chronic cough related to smoking, asthma, chronic bronchitis, or emphysema. The product may cause drowsiness and must be kept out of reach of children. In case of an overdose, medical attention is required, and it is recommended to consult a healthcare professional before use during pregnancy or breastfeeding. The recommended dosage must not be exceeded and the product must be stored at room temperature.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.